Table 6 Demographics and operative variables in cohort, n = 207
Range | Mean (±Standard Deviation (SD)) | |
|---|---|---|
Age, yr | 18–92 | 57,9 (±16,4) |
Height, m | 1,50 – 1,98 | 1,69 (±0,09) |
Weight, kg | 40–160 | 77 (±15,7) |
Body Mass Index (BMI) | 17,2–37,6 | 27,0 (±4,9) |
Duration of anaesthesia, min | 29–210 | 107 (±57) |
n | Percent | |
Gender, female | 165 | 79,7% |
American Society of Anesthesiologists Status: | ||
ASA I | 71 | 34,3% |
ASA II | 112 | 54,1% |
ASA III | 22 | 10,6% |
ASA IV | 2 | 1,0% |
Planned Surgery | 178 | 86,0% |
Type of surgery | ||
Orthopaedic - total Knee/total hip joint replacement Fracture fixation Other | 99 28 / 50 19 2 | 47,8% 13,5% / 24,2% 9,2% 1,0% |
Gynaecological - total Vaginal/open hysterectomy Laparascopic hysterectomy Vaginal repair surgery Caesarean section Other | 94 37 / 7 22 16 8 4 | 45,4% 17,9% / 3,4% 10,6% 7,7% 3,9% 1,9% |
Ear, nose and throat - tonsillectomy | 14 | 6,8% |
Type of anaesthesia | ||
“Target”-control infusion(TCI) of propofol and remifentanil | 94 | 45,4% |
Spinal anaesthesia(SA)/Epidural anaesthesia(EDA) ± sedation(sed) | 73 / 2 | 35,2% / 1,0% |
TCI + EDA/Regional block(RB)/SA | 28 / 2 / 2 | 13,5% / 1,0% / 1,0% |
Gas anaesthesia(GA): sevoflurane and fentanyl | 6 | 2,9% |